"President Trump on Tuesday announced a deal with Pfizer to sell its drugs directly to consumers at discounted prices. They'll be available through a website operated by the federal government called TrumpRx.gov. He said similar deals with other drugmakers are in the works. The new website is part of a broader initiative the administration says is aimed at bringing prices paid by Americans, including Medicaid patients, more in line with those paid in other developed countries. The idea is sometimes called most-favored-nation pricing."
"Under the deal, Pfizer agreed to charge the same price for new drugs in developed countries and the U.S. "The American consumers have been subsidizing research and development for the entire planet," Trump said in a press conference, joined by his health team and Pfizer CEO Albert Bourla. "They put all of that on us, and yet they were the beneficiaries too. So it's been changed." "I think today we are turning the tide, and we are reversing an unfair situation,""
President Trump announced a deal with Pfizer to sell its drugs directly to consumers at discounted prices through a federal website called TrumpRx.gov. The initiative aims to align U.S. drug prices, including those for Medicaid patients, with prices in other developed countries using most-favored-nation pricing. Pfizer agreed to charge the same price for new drugs in developed countries and the U.S. The website is expected to launch in 2026 and will link consumers to pharmaceutical companies' direct-to-consumer fulfillment sites. Pfizer projects direct-to-consumer prices on TrumpRx.gov will be about 50% lower on average, while specific terms remain confidential.
Read at www.npr.org
Unable to calculate read time
Collection
[
|
...
]